Stockreport

Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference [Yahoo! Finance]

Unicycive Therapeutics, Inc.  (UNCY) 
PDF clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that two presentations related [Read more]